Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05176392 · ClinicalTrials.gov registry record · NA
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
A NA study of Depression and Headache, sponsored by Veterans Medical Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05176392: Recruiting NA study of Depression and Headache, sponsored by Veterans Medical Research Foundation.
NCT05176392 is a NA study of Depression and Headache that is actively recruiting participants, run by Veterans Medical Research Foundation. The registered enrollment target is 240 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05176392, a NA study of Depression and Headache, is actively recruiting participants, sponsored by Veterans Medical Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.
Primary Outcome
Assesses the intensity of persistent headaches, from a scale of 0, being no pain, to 10, being worst possible pain.
Conditions Studied
Interventions
- DEVICE Active rTMS
- DEVICE Sham rTMS
- BEHAVIORAL Headache Management Therapy
- BEHAVIORAL Headache Education Control
Study Locations (1)
California
- VA San Diego Healthcare System - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT05176392 shows while recruiting
NCT05176392 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Active rTMS is the first listed.
NCT05176392 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05176392 about?
NCT05176392 is a clinical study titled "Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches". This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide m...
What is the current status of trial NCT05176392?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2022-01-01. Estimated completion is 2025-08-31.
What conditions does trial NCT05176392 study?
This clinical trial studies the following conditions: Depression, Headache, TBI (Traumatic Brain Injury).
What interventions are being tested in trial NCT05176392?
The interventions under investigation include: Active rTMS (DEVICE), Sham rTMS (DEVICE), Headache Management Therapy (BEHAVIORAL), Headache Education Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05176392?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05176392 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05176392's enrollment target sits among peer trials
240 177th of 679 higher than 494 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy